In both melanoma and RCC, serum vascular endothelium growth factor (VEGF) and fibronectin have also been identified as independent predictors of non response, and high levels of these proteins have been correlated with a lack of clinical response and decreased overall survival. This evidence concerns the gene FN1 and renal cell carcinoma.